Delivering quality therapy since 1901
  • Press releases

    Richter and Allergan Provide Update on Cariprazine Program

    BUDAPEST, Hungary and DUBLIN, Ireland – Allergan plc (NYSE: AGN), a leading global pharmaceutical company and Gedeon Richter Plc., today provided a clinical and regulatory update on cariprazine. For more than a decade both companies have conducted  over 20 clinical trials enrolling thousands of patients worldwide to evaluate the  efficacy and safety of cariprazine for patients suffering from a broad range of mental health illnesses. 

     

  • in Focus

    Gynaecology

    Gynaecological therapy is a focus area for Richter. The company has several decades of unparalleled experience in this area. The first steroid experiments were conducted by the company’s founder, Gedeon Richter himself. Our company was the first pharmaceutical company to put a contraceptive on the Hungarian market, in 1966.

  • Central Nervous System
  • Cardiology
Loading...

​​​​​ ​​​​​ ​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​